Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of remimazolam versus propofol for general anesthesia during elective surgery
2018-000174-29Phase 3Terminated
- Sponsor
- PAION AG
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of remimazolam and propofol in general anesthesia (2 arms), sponsored by PAION AG. Primary endpoint: Primary efficacy endpoint. Started Apr 2018; status: terminated.
02
Drugs
remimazolampropofol
03
Conditions
general anesthesia
Beyond the preview
Go deeper on 2018-000174-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000174-29.